Jump to content

20250188102. Triazine Compound, Int (JKT BIOPHARMA ., .)

From WikiPatents

TRIAZINE COMPOUND, INTERMEDIATE THEREOF, PREPARATION METHOD THEREFOR AND USE THEREOF

Abstract: a triazine compound, an intermediate thereof, and a preparation method therefor and the use thereof. specifically, the present invention relates to a triazine derivative as represented by formula (i′) or a pharmaceutically acceptable salt thereof. on the basis of retaining the effectiveness against sars-cov-2, the compound significantly prolongs the half-life period, reduces the dosage requirement, reduces side effects, expands the range of therapeutic window, and has very good prospects when used for manufacturing a drug for treating diseases related to coronavirus infections.

Inventor(s): Xiaokun SHEN, Jinwen HUANG

CPC Classification: C07F9/65583 (ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM (metal-containing porphyrins ))

Search for rejections for patent application number 20250188102


Cookies help us deliver our services. By using our services, you agree to our use of cookies.